Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | y003145 | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | 2052020 | OT |
administered after temperature excursions; no adverse event; This spontaneous report was received from Other Health Professional and refers to a currently 3-months-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient started therapy with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # y003145, expiration date: 12-SEP-2026, administered for prophylaxis (strength, dose, dose number, frequency, scheme, anatomical location, and route of administration were not provided); and on an unknown date, the patient started therapy with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # 2052020, expiration date: 10-MAR-2026, administered orally for prophylaxis (strength, dose, dose number, frequency, and scheme were not provided); (Improper storage of product in use). The vaccine underwent a temperature excursion during 1h 30 m under 60 Fahrenheit Degrees. No previous temperature excursions. No adverse event reported. This case was previously reported as non-valid due to lack of individual patient identifiers, but upon follow-up information on 17-JAN-2025, was updated to valid. This case was one of three from the same reporter. ; Sender's Comments: US-009507513-2501USA004754:Original Case : 2501USA004754 US-009507513-2502USA000138:Original Case : 2501USA004754